Ca-AKG (Calcium Alpha-Ketoglutarate).

Alpha-ketoglutarate is the co-substrate that the 2-oxoglutarate dependent dioxygenases consume, and ascorbate keeps the iron at their active site in the reduced state so the cycle can continue. The two are required together for prolyl hydroxylases and the demethylase families to turn over.

Every 2-oxoglutarate dependent dioxygenase holds a ferrous iron at its active site, and alpha-ketoglutarate binds alongside it before the oxygen step. Without iron the alpha-ketoglutarate co-substrate has no enzyme to feed.

Prolyl hydroxylase converts proline residues to hydroxyproline using alpha-ketoglutarate, iron and ascorbate, and hydroxyproline is what lets the collagen triple helix hold. Proline supplies the residue while alpha-ketoglutarate drives the hydroxylation.

Newly assembled collagen chains need proline and lysine hydroxylation, both carried out by alpha-ketoglutarate dependent enzymes. Supplying the peptide substrate alongside the enzyme co-substrate covers both halves of the step.

Glycine occupies every third position in the collagen helix while alpha-ketoglutarate drives the hydroxylation that stabilises it. The two contribute to different requirements of the same assembly.

Ornithine feeds the urea cycle while alpha-ketoglutarate accepts ammonia through glutamate dehydrogenase to form glutamate and then glutamine. The two are combined as ornithine alpha-ketoglutarate precisely because they clear ammonia by complementary routes.

Aminotransferases move amino groups onto alpha-ketoglutarate to make glutamate, and every one of them needs pyridoxal-5-phosphate as its cofactor. B6 status sets how readily alpha-ketoglutarate is used in this direction.

The calcium carried in calcium alpha-ketoglutarate reduces non-heme iron uptake when the two are taken in the same dose window, an interaction that sits at the shared enterocyte transport step. Separating the doses avoids it.

Calcium alpha-ketoglutarate delivers a calcium load, and vitamin K2 carboxylates osteocalcin and matrix Gla protein, the proteins that determine where that calcium is deposited. The pairing addresses supply and placement.

The E2 subunit of the alpha-ketoglutarate dehydrogenase complex carries a lipoyl group that shuttles the succinyl unit during the reaction. Without functional lipoamide the complex cannot process alpha-ketoglutarate onward to succinyl-CoA. That makes the relationship a direct cofactor dependency rather than a speculative pairing.

Alpha-ketoglutarate is decarboxylated by a thiamine pyrophosphate dependent enzyme, the same cofactor chemistry that pyruvate dehydrogenase uses. Low thiamine availability slows that step and alpha-ketoglutarate accumulates upstream. Supplying the substrate without the cofactor does not move the pathway.

The third subunit of the alpha-ketoglutarate dehydrogenase complex re-oxidises the lipoamide arm using FAD and passes the electrons to NAD+. Riboflavin status therefore sits directly on the route alpha-ketoglutarate takes through the citric acid cycle. This is settled enzymology and needs no trial.

Converting alpha-ketoglutarate to succinyl-CoA reduces NAD+ to NADH, so the reaction stops when the oxidised pool is depleted. Niacin supplies the precursor for that pool. The pairing is stoichiometric biochemistry rather than an observed clinical combination.

Nicotinamide riboside raises NAD+ through the salvage route, and NAD+ is what accepts electrons when alpha-ketoglutarate is oxidised. The two are commonly combined in longevity-positioned formulas on that shared-cofactor reasoning. No human trial has measured the combination, so the grounding stays biochemical.

Alpha-ketoglutarate feeds reducing equivalents into the electron transport chain, where ubiquinone is the mobile carrier between complexes. The two sit on consecutive stretches of the same energy pathway. The connection is pathway architecture, not a demonstrated joint effect on any outcome.

Glutamine is deamidated to glutamate, and glutamate is transaminated or deaminated to alpha-ketoglutarate, which is how the amino acid enters the citric acid cycle. Supplying alpha-ketoglutarate provides the carbon skeleton on the other side of that same equilibrium. It also acts as a nitrogen acceptor, which is the basis for its long use in nitrogen-handling formulations.

Branched-chain aminotransferase moves the amino group from leucine onto alpha-ketoglutarate, producing glutamate and the corresponding keto acid. Availability of alpha-ketoglutarate is therefore part of what sets the rate of branched-chain amino acid handling. The pairing rests on transaminase chemistry, not on a combination study.

Arginine is sold as its own alpha-ketoglutarate salt, so the two have been co-administered for decades in sports formulations. Alpha-ketoglutarate accepts amino nitrogen and so intersects with the urea cycle substrates arginine feeds. The rationale is metabolic and formulation history rather than a controlled trial of the combination.

Hydroxylation of lysine residues in procollagen consumes alpha-ketoglutarate as a co-substrate alongside iron and ascorbate. Lysine supplies the residue and alpha-ketoglutarate supplies the co-substrate for the same reaction. This is the clearest structural reason the two appear in connective-tissue formulas together.

Calcium alpha-ketoglutarate delivers a meaningful amount of elemental calcium, and a large calcium load taken at once can reduce magnesium uptake in the same window. Separating the two by a few hours removes most of that overlap. The competition is about timing and dose, not about either mineral being unsuitable.

Large calcium doses taken with zinc in the same meal reduce zinc absorption, a well-described divalent cation interaction. Because the calcium here arrives as the counter-ion of the alpha-ketoglutarate salt, the calcium load is easy to overlook when totalling daily intake. Spacing the doses is the practical answer.

The calcium delivered by calcium alpha-ketoglutarate is absorbed partly by a vitamin D dependent active transport route, especially at lower intakes. Vitamin D status therefore affects how much of the counter-ion calcium is taken up. The relationship concerns the calcium, not the alpha-ketoglutarate.